Tag: vorasedenib
-
Vorasidenib: Accept Or Reject?
In recent reports, it was announced that the National Institute for Health and Care Excellence (NICE) has declined to formalize the acceptance of the use of Vorasidenib on the National Health Service (NHS). Vorasidenib is a targeted therapy that is administered orally for patients with low-grade gliomas. This took place in October 2025 on the…
The Farah Saeed Project 